首页 > 市场调查报告书 > 製药

呼吸器

全球支气管扩张剂市场研究报告 - 行业分析、规模、份额、增长、趋势及2023至2030年预测

市场调查报告书

商品编码

1306994

全球支气管扩张剂市场研究报告 - 行业分析、规模、份额、增长、趋势及2023至2030年预测

Global Bronchodilators Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年05月01日 | 出版商:

Value Market Research | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球支气管扩张剂市场需求预计将从2022年的238.7亿美元增长到2030年的350.5亿美元，2023-2030年的复合年增长率为4.92%。

支气管扩张剂是一种药物，有助于打开或扩张肺部气道，使呼吸更顺畅。它们通常用于治疗哮喘、慢性阻塞性肺病（COPD）和其他导致呼吸困难的呼吸系统疾病。这些药物通过放松肺部气道周围的肌肉发挥作用，从而使气道变宽并改善气流。

市场动态：

由于哮喘、慢性阻塞性肺病和支气管炎等呼吸系统疾病的发病率不断上升，支气管扩张剂市场正经历着显著增长。随着这些疾病的全球发病率不断上升，对高效药物的需求也在增加。人们对保持呼吸系统健康重要性的认识不断提高是推动该市场发展的另一个因素。人们越来越意识到呼吸系统疾病的相关风险，并采取措施预防和控制这些疾病，其中包括使用支气管扩张药物。新型给药技术的发展也推动了该市场的发展。计量吸入器、干粉吸入器和雾化器等吸入装置正变得越来越先进，使患者能够更方便、更容易地使用这些药物。全球老年人口不断增加，推动了对支气管扩张药物的需求。老年人更易患呼吸系统疾病，通常需要长期使用支气管扩张剂来控制症状。制药公司正投入巨资进行研发，以开发更有效的新药。这推动了该领域的创新，并开发出新的有效治疗方法。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清楚地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对支气管扩张剂全球市场的各个细分市场进行了全面评估。支气管扩张剂行业的增长和趋势为本研究提供了整体方法。

市场细分：

支气管扩张剂市场报告的这一部分提供了国家和地区层面细分市场的详细数据，从而帮助战略家确定各自产品或服务的目标人群以及即将到来的机会。

按药物类别

β-肾上腺素能支气管扩张剂
黄嘌呤衍生物
抗胆碱能支气管扩张剂

按给药途径

口服
鼻用（可吸入）
注射剂

按疾病分类

哮喘
慢性阻塞性肺病（COPD）
其他疾病

区域分析

本节涵盖区域展望，重点介绍北美、欧洲、亚太、拉美、中东和非洲地区支气管扩张剂市场的当前和未来需求。此外，报告还重点介绍了所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场中主要企业的综合概况以及全球竞争格局的深入分析。支气管扩张剂市场的主要参与者包括罗氏公司、葛兰素史克公司、强生公司、阿斯利康公司、西门子医疗保健公司、雅培公司、Bio-Rad实验室公司、赛默飞世尔科技公司、Quest Diagnostics公司、FOUNDATION MEDICINE公司、GSK公司、ASTRAZENECA公司、SIEMENS Healthcare GmbH公司、Abbott公司、Bio-Rad实验室公司、Thermo Fisher Scientific公司、Quest Diagnostics公司、FOUNDATION MEDICINE, INC.本部分包括竞争格局的整体视图，其中包括各种战略发展，如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。

地区展望
产品介绍
北美销售分析
- 概述、历史和预测数据销售分析
- 北美细分市场销售分析
- 北美各国销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概述、历史和预测数据销售分析
- 欧洲销售分析
- 欧洲各国销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 意大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概述、历史和预测数据销售分析
- 亚太地区细分市场销售分析
- 亚太地区各国销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳大利亚销售分析
- 亚太其他地区销售分析
拉丁美洲销售分析
- 概述、历史和预测数据销售分析
- 拉丁美洲各细分市场销售分析
- 拉丁美洲各国销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概述、历史和预测数据销售分析
- 中东及非洲地区销售分析
- 中东及非洲国家销售分析
- 沙特阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东和非洲其他地区销售分析

第九章支气管扩张剂企业竞争格局

支气管扩张剂市场竞争
伙伴关系/合作/协议
合并与收购
新产品上市
其他发展

第10章 : 公司简介

公司份额分析
市场集中率
F. Hoffmann-La Roche Ltd
- 公司概况
- 公司收入
- 公司产品
- 近期发展
GSK plc.
- 公司概况
- 公司收入
- 产品
- 近期发展
Johnson & Johnson Services Inc.
- 公司概况
- 公司收入
- 产品
- 近期发展
AstraZeneca
- 公司概况
- 公司收入
- 产品
- 近期发展
Siemens Healthcare GmbH
- 公司概况
- 公司收入
- 产品
- 近期发展
Abbott
- 公司概况
- 公司收入
- 产品
- 近期发展
Bio-Rad Laboratories Inc.
- 公司概况
- 公司收入
- 产品
- 近期发展
Thermo Fisher Scientific
- 公司概况
- 公司收入
- 产品
- 近期发展
Quest Diagnostics Incorporated.
- 公司概况
- 公司收入
- 产品
- 近期发展
FOUNDATION MEDICINE INC.
- 公司概况
- 公司收入
- 产品
- 近期发展

注-在公司概况中，财务细节和近期发展视情况而定，如果是私营公司则可能不包括在内。

简介目录图表

Product Code: VMR112111165

The global demand for Bronchodilator Market is presumed to reach the market size of nearly USD 35.05 BN by 2030 from USD 23.87 BN in 2022 with a CAGR of 4.92% under the study period 2023 - 2030.

A bronchodilator is a medication that helps to open up or dilate the air passages in the lungs, making it easier to breathe. They are typically used to treat asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders that cause difficulty breathing. These medicines work by relaxing the muscles that surround the airways in the lungs, which allows the air passages to widen and improve airflow.

Market Dynamics:

The bronchodilator market is experiencing significant growth due to the escalating prevalence of respiratory disorders like asthma, COPD, and bronchitis. With the global incidence of these conditions on the rise, the demand for efficient medications is also increasing. The growing awareness about the importance of maintaining good respiratory health is another factor driving this market. People are becoming more aware of the risks associated with respiratory disorders and are taking steps to prevent and manage these conditions, which includes the use of bronchodilator medications. The development of new drug delivery technologies is also driving the market. Inhalation devices such as metered-dose inhalers, dry powder inhalers, and nebulizers are becoming more advanced, making it more convenient and easy for patients to administer these medications. The global geriatric population is increasing, which is driving the demand for bronchodilator medications. The elderly are more susceptible to respiratory disorders and often require long-term treatment with bronchodilators to manage their symptoms. Pharmaceutical companies are investing heavily in research and development to develop new and more effective medications. This is driving innovation in the field and leading to the development of new effective treatments.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of bronchodilator. The growth and trends of bronchodilator industry provide a holistic approach to this study.

Market Segmentation:

This section of the bronchodilator market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

Beta-Adrenergic Bronchodilators
Xanthine Derivatives
Anticholinergic Bronchodilators

By Route Of Administration

Oral
Nasal (Inhalable)
Injectable

By Disease

Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Bronchodilator market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the bronchodilator market include F. Hoffmann-La Roche Ltd, GSK plc., Johnson & Johnson Services, Inc., AstraZeneca, Siemens Healthcare GmbH, Abbott, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Quest Diagnostics Incorporated., FOUNDATION MEDICINE, INC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BRONCHODILATOR - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Class
- 3.7.2 Market Attractiveness Analysis By Route Of Administration
- 3.7.3 Market Attractiveness Analysis By Disease
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BRONCHODILATOR MARKET ANALYSIS BY DRUG CLASS

5.1 Overview by Drug Class
5.2 Historical and Forecast Data
5.3 Analysis by Drug Class
5.4 Beta-Adrenergic Bronchodilators Historic and Forecast Sales by Regions
5.5 Xanthine Derivatives Historic and Forecast Sales by Regions
5.6 Anticholinergic Bronchodilators Historic and Forecast Sales by Regions

6 . GLOBAL BRONCHODILATOR MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

6.1 Overview by Route Of Administration
6.2 Historical and Forecast Data
6.3 Analysis by Route Of Administration
6.4 Oral Historic and Forecast Sales by Regions
6.5 Nasal (Inhalable) Historic and Forecast Sales by Regions
6.6 Injectable Historic and Forecast Sales by Regions

7 . GLOBAL BRONCHODILATOR MARKET ANALYSIS BY DISEASE

7.1 Overview by Disease
7.2 Historical and Forecast Data
7.3 Analysis by Disease
7.4 Asthma Historic and Forecast Sales by Regions
7.5 Chronic Obstructive Pulmonary Disease (COPD) Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL BRONCHODILATOR MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE BRONCHODILATOR COMPANIES

9.1. Bronchodilator Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF BRONCHODILATOR INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. F. Hoffmann-La Roche Ltd
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. GSK plc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Johnson & Johnson Services Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. AstraZeneca
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Siemens Healthcare GmbH
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Abbott
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Bio-Rad Laboratories Inc.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Thermo Fisher Scientific
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Quest Diagnostics Incorporated.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. FOUNDATION MEDICINE INC.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments